Glacier Peak Capital’s Sanofi SNY Stock Holding History

Glacier Peak Capital’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-35,000	Closed	-$1.42M	–	73
2016 Q4	$1.42M	Buy	+35,000	New	+$1.38M	0.81%	34

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Glacier Peak Capital's SNY Position: Q1 2017 in Review

Glacier Peak Capital sold out of Sanofi (SNY) in Q1 2017, closing a stake of 35,000 shares — an estimated $1.42M sold.

Glacier Peak Capital first reported a position in SNY in Q4 2016 and held it in 1 quarter. The position peaked at $1.42M in Q4 2016. 455 funds tracked by Wall St. Rank hold SNY as of Q1 2017.

Glacier Peak Capital reported no remaining Sanofi position as of Q1 2017 after selling out during the quarter.
Glacier Peak Capital sold 35,000 Sanofi shares in Q1 2017, an estimated $1.42M.
Glacier Peak Capital first reported a position in Sanofi in Q4 2016 and held it in 1 quarter.
Glacier Peak Capital's Sanofi position peaked at $1.42M in Q4 2016.
455 funds tracked by Wall St. Rank held Sanofi as of Q1 2017.

Based on Glacier Peak Capital's 13F filing for Q1 2017, filed 12 May 2017.